BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28133609)

  • 21. Context and Applications of Targeted Genetic Testing, with Emphasis on Copy Number Variants.
    Ahn JW; Ogilvie C
    Adv Clin Chem; 2016; 75():33-51. PubMed ID: 27346615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients.
    Eliason K; Hendrickson BC; Judkins T; Norton M; Leclair B; Lyon E; Ward B; Noll W; Scholl T
    J Med Genet; 2005 Jan; 42(1):95-6. PubMed ID: 15635083
    [No Abstract]   [Full Text] [Related]  

  • 23. Copy number variation and autism: new insights and clinical implications.
    Chung BH; Tao VQ; Tso WW
    J Formos Med Assoc; 2014 Jul; 113(7):400-8. PubMed ID: 24961180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy.
    Funke S; Timofeeva M; Risch A; Hoffmeister M; Stegmaier C; Seiler CM; Brenner H; Chang-Claude J
    Pharmacogenomics; 2010 Jan; 11(1):33-41. PubMed ID: 20017670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can precision medicine reduce overdiagnosis?
    Hunt S; Jha S
    Acad Radiol; 2015 Aug; 22(8):1040-1. PubMed ID: 26100198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New era of laboratory testing. Topics: I. Generals; 4. Role of laboratory tests in personalized medicine].
    Nakatani K
    Nihon Naika Gakkai Zasshi; 2013 Dec; 102(12):3103-9. PubMed ID: 24605557
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fecal DNA analysis--future method for colorectal cancer screening?].
    Olsson L
    Lakartidningen; 2004 Nov; 101(47):3762-5. PubMed ID: 15609528
    [No Abstract]   [Full Text] [Related]  

  • 28. [What screening strategy should be recommended to the relatives of patients diagnosed with colorectal cancer?].
    Giráldez Jiménez MD
    Gastroenterol Hepatol; 2009 Jan; 32(1):57-8. PubMed ID: 19174101
    [No Abstract]   [Full Text] [Related]  

  • 29. First Amsterdam, then Bethesda, now Melbourne?
    Lenz HJ
    J Clin Oncol; 2005 Sep; 23(27):6445-9. PubMed ID: 16116155
    [No Abstract]   [Full Text] [Related]  

  • 30. Hereditary colorectal cancer: more common than you think.
    Jasperson KW
    Curr Probl Cancer; 2014; 38(6):249-61. PubMed ID: 25497411
    [No Abstract]   [Full Text] [Related]  

  • 31. The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value.
    Jiang X; Pissaloux D; De La Fouchardiere C; Desseigne F; Wang Q; Attignon V; Fondrevelle ME; De La Fouchardiere A; Perol M; Cassier P; Seigne C; Perol D; Ray-Coquard I; Meeus P; Fayette J; Flechon A; Le Cesne A; Penel N; Tredan O; Blay JY
    Oncotarget; 2015 Sep; 6(28):26388-99. PubMed ID: 26317543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of nucleic acid testing in diagnosis and therapy.
    Chandra R
    MLO Med Lab Obs; 2016 Jun; 48(6):24-7. PubMed ID: 27451527
    [No Abstract]   [Full Text] [Related]  

  • 33. [Molecular diagnosis for cardiovascular diseases].
    Schulze-Bahr E; Klaassen S; Abdul-Khaliq H; Schunkert H
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1538. PubMed ID: 26445261
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular stool screening for colorectal cancer.
    Mak T; Lalloo F; Evans DG; Hill J
    Br J Surg; 2004 Jul; 91(7):790-800. PubMed ID: 15227685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplex ligation-dependent probe amplification (MLPA) screening for exon copy number variation in the calcium sensing receptor gene: no large rearrangements identified in patients with calcium metabolic disorders.
    Nissen PH; Christensen SE; Wallace A; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):758-62. PubMed ID: 19912241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests.
    Berger BM; Schroy PC; Rosenberg JL; Lai-Goldman M; Eisenberg M; Brown T; Rochelle RB; Billings PR
    Clin Colorectal Cancer; 2006 Jan; 5(5):338-43. PubMed ID: 16512992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic information and prevention].
    Tönnies H; Schaade L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):111-2. PubMed ID: 25585840
    [No Abstract]   [Full Text] [Related]  

  • 38. [Personalized medicine--the future is already here].
    Abadi-Korek I; Shemer J
    Harefuah; 2011 May; 150(5):451-2, 490. PubMed ID: 21678641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics and Genetic Testing in Hereditary Colorectal Cancer.
    Stoffel EM; Boland CR
    Gastroenterology; 2015 Oct; 149(5):1191-1203.e2. PubMed ID: 26226567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic testing and gene--based testing for colorectal cancer].
    Yabana T; Goto A; Arimura Y; Shinomura Y; Imai K
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():217-22. PubMed ID: 16416797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.